![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | RGD:1621989 | 6480464 | ethylene dichloride results in decreased expression of NUP62CL mRNA | CTD | PMID:28960355 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1564353 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NUP62CL mRNA | CTD | PMID:22808131 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1564353 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NUP62CL mRNA | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1621989 | 6480464 | bis4-hydroxyphenylsulfone results in increased expression of NUP62CL mRNA | CTD | PMID:30951980 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of NUP62CL protein | CTD | PMID:20106945 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of NUP62CL intron | CTD | PMID:30157460 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of NUP62CL mRNA | CTD | PMID:21632981 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of NUP62CL mRNA | CTD | PMID:23724009 | amphetamine | increases expression | ISO | RGD:1564353 | 6480464 | Amphetamine results in increased expression of NUP62CL mRNA | CTD | PMID:30779732 | arsane | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of NUP62CL promoter | CTD | PMID:21291286 | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | arsenic atom | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of NUP62CL promoter | CTD | PMID:21291286 | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of NUP62CL mRNA | CTD | PMID:21632981, PMID:32234424 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of NUP62CL 5' UTR | CTD | PMID:27901495 | bisphenol A | affects expression | ISO | RGD:1564353 | 6480464 | bisphenol A affects the expression of NUP62CL mRNA | CTD | PMID:25181051 | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of NUP62CL mRNA | CTD | PMID:24376830 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of NUP62CL mRNA | CTD | PMID:16002434 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of NUP62CL mRNA | CTD | PMID:25979313 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of NUP62CL mRNA | CTD | PMID:27392435 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of NUP62CL mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NUP62CL mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of NUP62CL mRNA | CTD | PMID:19549813 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NUP62CL mRNA | CTD | PMID:20106945, PMID:27989131 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NUP62CL mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NUP62CL mRNA | CTD | PMID:28986285 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of NUP62CL mRNA | CTD | PMID:24449571 | oxaliplatin | multiple interactions | ISO | RGD:1564353 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NUP62CL mRNA | CTD | PMID:25729387 | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of NUP62CL mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NUP62CL mRNA | CTD | PMID:27188386 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NUP62CL mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NUP62CL mRNA | CTD | PMID:26690555 | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of NUP62CL mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of NUP62CL mRNA | CTD | PMID:25351596 | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of NUP62CL mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | thalidomide | decreases expression | ISO | RGD:1621989 | 6480464 | Thalidomide results in decreased expression of NUP62CL mRNA | CTD | PMID:26217789 | topotecan | multiple interactions | ISO | RGD:1564353 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NUP62CL mRNA | CTD | PMID:25729387 | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of NUP62CL mRNA | CTD | PMID:23228038 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of NUP62CL mRNA | CTD | PMID:30510588 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NUP62CL mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NUP62CL mRNA | CTD | PMID:24383497 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NUP62CL mRNA | CTD | PMID:27188386 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of NUP62CL mRNA | CTD | PMID:27188386 | |